Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4T5B5 | — |
an expired dose of Arexvy was administered to a 63 years old male patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 63-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 4T5B5, expiry date 02-MAR-2025) for prophylaxis. On 05-MAR-2025, the patient received Arexvy. On 05-MAR-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: an expired dose of Arexvy was administered to a 63 years old male patient). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 05-MAR-2025 The medical assistant called to reported that they administered an expired dose of Arexvy patient on the day of reporting which led to, expired vaccine used. The reported wanted to know was there any supplemental potency data.